VitaNova Life Sciences (VNOV) Non-Current Assets (2017 - 2018)
VitaNova Life Sciences (VNOV) reported Non-Current Assets of $38929.0 for Q3 2018, up 25.33% quarter-over-quarter from $31061.0 in Q2 2018.
VitaNova Life Sciences (VNOV) Non-Current Assets (2017 - 2018) Analysis & Trends
VitaNova Life Sciences has reported Non-Current Assets for 2 years, with the latest figure at $38929.0 in Q3 2018.
- For the quarter ending Q3 2018, Non-Current Assets changed N/A year-over-year to $38929.0; the trailing twelve-month figure through Jul 2018 stood at $38929.0 (changed N/A YoY), and the FY2018 full-year result was $31061.0, up 291.94% from the prior year.
- Non-Current Assets for Q3 2018 stood at $38929.0, up from $31061.0 in the prior quarter.
- The five-year high for Non-Current Assets was $64700.0 in Q4 2017, with the low at $7925.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 193.66 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 25.11 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 28.51 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 18.63 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 6.81 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 1.83 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 20.59 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 10.63 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 25.48 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2018 | 38,929.00 |
| Apr 30, 2018 | 31,061.00 |
| Jan 31, 2018 | 51,950.00 |
| Oct 31, 2017 | 64,700.00 |
| Apr 30, 2017 | 7,925.00 |